1st Quarter - Report

TODD STRATEGY GROUP for BIODESIX, INC.

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Implementation of changes to Medicare payments for clinical laboratory tests. Medicare treatment of outpatient reimbursement for laboratory tests. FDA regulation of laboratory developed tests (LDTs).

LobbyistCovered position, as disclosed
PAUL EDATTEL Chief Health Counsel, House Energy & Commerce Committee; Policy Assistant, Office of the Speaker; Professional Staff Member for the Majority at the House Energy & Commerce Committee; Legislative Assistant & Legislative Director, Rep. John Shadegg
DANIEL M TODD Senior Health Counsel, Senate Finance Committee; Special Assistant, Office of Admin. Ct. - Medicare & Medicaid

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE

Medical/Disease Research/Clinical Labs MED

FDA regulation of laboratory developed tests.

LobbyistCovered position, as disclosed
PAUL EDATTEL —
DANIEL M TODD —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS)

Health Issues HCR

COVID-19 Response.

LobbyistCovered position, as disclosed
PAUL EDATTEL —
DANIEL M TODD —

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.